Bonesupport enrols first patient in injectable bone graft substitute trial
European Pharmaceutical Review | May 22, 2017
Bonesupport, the Scandinavian medical technology company, has enrolled their first patient at the University of Texas Health Science Center at San Antonio into the company’s pivotal Investigational Device Exemption (IDE) trial.